Moleculin Biotech, Inc.
MBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $146 | $636 | $758 | $1,250 |
| - Cash | $4 | $24 | $43 | $71 |
| + Debt | $0 | $1 | $0 | $0 |
| Enterprise Value | $143 | $613 | $715 | $1,179 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$27 | -$30 | -$31 | -$23 |
| % Margin | – | – | – | – |
| Net Income | -$22 | -$30 | -$29 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -158 | -376.75 | -380.5 | -221.75 |
| % Growth | 58.1% | 1% | -71.6% | – |
| Operating Cash Flow | -$24 | -$24 | -$28 | -$19 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$24 | -$24 | -$28 | -$19 |